This clinical trial is assessing whether an investigational vaccine can safely and effectively prevent chlamydia infections among young adults.
The study is being conducted at our Brisbane and Canberra clinics.
This 6-month study is exploring whether changing the formulation methods of mRNA-based RSV vaccines provides better protection and fewer side effects than currently approved vaccines.
This study is being conducted at our Brisbane clinic.
